Skip to content
Screener

Hims & Hers Health HIMS Merger-related charges and other

Merger-related charges and other at other companies

Hims & Hers Health logo
Hims & Hers HealthHIMS
$6.37M+518%
Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
$890.82K
CTO
Citius Oncology, Inc.CTOR
$2.75M0.0%
ROC
Rank One ComputingROC
$32.83K-11.6%
SB Financial Group logo
SB Financial GroupSBFG
$700K0.0%
WesBanco logo
WesBancoWSBC
$3.71M-81.4%

Other financials

Income statement

See full
Revenue$608.1M+3.8%
Gross profit$396.8M-7.9%
Operating income-$78.3M-235%
Net income-$92.1M-286%
EPS (diluted)-$0.40-300%

Balance sheet

See full
Cash & equivalents$222.3M-19.2%
Total debt$157.9M+149%
Total equity$446.2M-18.8%
Total assets$2.3B+154%

Cash flow

See full
Operating cash flow$89.4M-18.1%
CapEx$8.8M-19.9%
Free cash flow$80.5M-17.9%

Valuation

See full
Market cap$6.87B-40.6%
Enterprise value$6.8B-35.3%
P/S2.9×-2.8×

Profitability

See full
Gross margin71.7%-5.3pp
Operating margin-1.3%-7.5pp
Net margin-0.6%-9.8pp
FCF margin11.9%-5.8pp

Returns & leverage

See full
Return on equity-2.7%-39.4pp
Debt / equity0.4×+0.2×
Current ratio1.7×+0.1×

Where this comes from

Reported directly by Hims & Hers Health in its filing.

Tagged under the XBRL concept us-gaap:NoncashMergerRelatedCosts.

The source filing: Hims & Hers Health’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001773751-26-000076
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Benefit from deferred taxes(13,975)(890)
Amortization of debt discount and issuance costs1,701
Non-cash operating lease cost4,5821,905
Non-cash acquisition-related costs6,3671,030
Non-cash restructuring and other related charges included within cost of revenue28,462
Non-cash other982832
Changes in operating assets and liabilities:
Receivables, net(116,247)(864)

Item 1. Financial Statements

FAQ

What is Hims & Hers Health's merger-related charges and other?
Hims & Hers Health (HIMS) reported merger-related charges and other of $6.37M in Q1 2026.
How has Hims & Hers Health's merger-related charges and other changed year-over-year?
Hims & Hers Health's merger-related charges and other increased by 518.2% year-over-year, from $1.03M to $6.37M.
What is the long-term trend for Hims & Hers Health's merger-related charges and other?
Over 4 years (2021 to 2025), Hims & Hers Health's merger-related charges and other has grown at a 49.4% compound annual growth rate (CAGR), from $1.18M to $5.89M.
What does merger-related charges and other mean?
This represents non-cash expenses recognized in connection with business combinations, such as the amortization of acquired intangible assets or adjustments to contingent consideration. It isolates the accounting impact of M&A activity from core operational cash flows to provide a clearer view of underlying business performance.

Ask your AI about Hims & Hers Health's merger-related charges and other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude